Accupril and Accuretic recall in Canada: nitrosamine impurity
In plain language
This recall involves Accupril and Accuretic blood pressure medications sold in Canada. They are being recalled because they contain a nitrosamine impurity above acceptable levels. Continue taking your medication unless advised to stop by your healthcare provider, and contact them to discuss other treatment options.
What to do
- Continue taking your medication unless advised to stop by your healthcare provider.
- Contact your healthcare provider to discuss other treatment options.
- Do not return the medication to your pharmacy.
- Contact Pfizer Canada ULC for questions about the recall.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Accupril 10mg
Lot: CK5285, DY3042
Date codes: 2022-05-31, 2023-03-31
Accupril 20mg
Lot: CK6258, CK6259, DT9592
Date codes: 2022-05-31, 2023-03-31
Accupril 40mg
Lot: CM2828, CM2829, DT9591
Date codes: 2022-05-31, 2023-03-31
Accuretic 10/12.5mg
Lot: EJ5192, FA3736, FM9526
Date codes: 2022-07-31, 2023-08-31
Accuretic 20/12.5mg
Lot: EF3087, ET9511, EX4411
Date codes: 2022-07-31
Accuretic 20/25mg
Lot: EA0781, FA9224
Date codes: 2022-07-31
Why this matters
Increased cancer risk from long-term exposure
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the date code
Date codes are usually printed near the best-before date or on the packaging seam.
Affected date codes: 2022-05-31, 2022-07-31, 2023-03-31, 2023-08-31
- 3
Check the lot number
Lot numbers identify specific production batches.
Affected lots: CK5285, CK6258, CK6259, CM2828, CM2829, DT9591, DT9592, DY3042, EA0781, EF3087, EJ5192, ET9511, EX4411, FA3736, FA9224, FM9526
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Increased cancer risk from long-term exposure
What should consumers do?
Continue taking your medication unless advised to stop by your healthcare provider. Contact your healthcare provider to discuss other treatment options. Do not return the medication to your pharmacy. Contact Pfizer Canada ULC for questions about the recall.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Increased cancer risk from long-term exposure
When was this product recalled?
This product was recalled on April 21, 2022.
Is the Accupril, Accuretic brand affected by this recall?
Yes, Accupril, Accuretic products are affected by this recall. This recall involves Accupril and Accuretic blood pressure medications sold in Canada. They are being recalled because they contain a nitrosamine impurity above acceptable levels. Continue taking your medication unless advised to stop by your healthcare provider, and contact them to discuss other treatment options.